Biocon Biologics is promoting its branded formulations enterprise to Mumbai-based Eris Lifesciences for Rs 1242 crore.With the deal, Eris will jumpstart its entry into the Rs 30,000+ crore injectables market in India, and purchase two main insulin manufacturers – Basalog and Insugen. This acquisition will even mark Eris’ entry into…
-
-
What’s ‘pink tax’ Biocon chief complained about?
Kiran Mazumdar-Shaw, the founder and government chairperson of Indian Biopharmaceutical Firm Biocon, posted a video on X to protest discriminatory pricing for merchandise used ideally by girls.Mazumdar-Shaw wrote, “Pink Tax! A shameful gender bias that women must respond to by shunning such products.”What’s ‘pink tax’?In keeping with the World Financial…